Greenwood Genetic Center Cytogenetics Lab Director Dr. Alka Chaubey (left) and Senior Director Dr. Barbara DuPont show off the FDA approved chip they helped create.
(MADDY JONES | INDEX-JOURNAL)
Greenwood Genetic Center Cytogenetics Lab Director Dr. Alka Chaubey (left) and Senior Director Dr. Barbara DuPont show off the FDA approved chip they helped create. (MADDY JONES | INDEX-JOURNAL)

When Alka Chaubey received the news last month, she let out a shriek of excitement loud enough to shake the Education Center at the Greenwood Genetic Center.
Chaubey, a director of GGC's Cytogenetics Laboratory, and her counterparts at the Greenwood lab played a pivotal role in the trial process for a first-of-its-kind genetic testing that received federal approval recently. The cutting-edge technology received the U.S. Food and Drug


Administration's first ever clearance for a whole-genome procedure, which could revolutionize diagnostic testing for children suffering from intellectual disabilities.
"It's an ecstatic feeling," she said. "The only way I can tell you how we feel is who was the 10th person who climbed Mt. Everest or the 20th person who went on the moon? Nobody remembers that, you remember the first person. So, this is the first whole-genome test that the FDA has approved, and we are one of the sites. So, this is a big thing."

FOR MORE OF THE STORY READ THE INDEX-JOURNAL